Page contentsPage contentsKey factsDecisionKey facts Active Substance Ethanol Therapeutic area Cardiovascular diseases Decision number P/0016/2020 PIP number EMEA-002672-PIP01-19 Pharmaceutical form(s) Solution for infusion Condition(s) / indication(s) Treatment of uncontrolled primary hypertension Route(s) of administration Intraarterial use Contact for public enquiries Ablative Solutions Inc.E-mail: taf@ablativesolutions.com, nharatani@ablativesolutions.comTel. +1 4084212496 Decision type W: decision granting a waiver in all age groups for all conditions or indications Decision date 06/01/2020DecisionP/0016/2020: EMA decision of 6 January 2020 on the granting of a product specific waiver for ethanol (EMEA-002672-PIP01-19)AdoptedReference Number: EMA/659448/2019 English (EN) (378.65 KB - PDF)First published: 10/06/2020ViewShare this page